Align Technology, Inc.
General ticker "ALGN" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $12.7B (TTM average)
Align Technology, Inc. follows the US Stock Market performance with the rate: 5.6%.
Estimated limits based on current volatility of 2.2%: low 162.78$, high 170.08$
Factors to consider:
- Company included in S&P500 list
- Total employees count: 20945 (-3.1%) as of 2024
- US accounted for 42.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Economic downturns and volatility, Regulatory and compliance, Supply chain disruptions, Cybersecurity threats, Geopolitical risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [122.26$, 189.36$]
- 2026-12-31 to 2027-12-31 estimated range: [127.87$, 196.07$]
Financial Metrics affecting the ALGN estimates:
- Negative: with PPE of 15.1 at the end of fiscal year the price was high
- Positive: 7.67 < Operating profit margin, % of 15.27
- Positive: Return on assets ratio (scaled to [-100,100]) of 6.18 > 6.11
- Negative: negative Industry operating cash flow (median)
- Negative: Investing cash flow per share per price, % of -0.98 <= -0.63
- Positive: 0.01 < Operating cash flow per share per price, % of 5.16
Short-term ALGN quotes
Long-term ALGN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $3,862.26MM | $3,968.04MM | $4,034.96MM |
| Operating Expenses | $3,218.92MM | $3,360.42MM | $3,418.75MM |
| Operating Income | $643.34MM | $607.63MM | $616.22MM |
| Non-Operating Income | $-2.13MM | $1.33MM | $-30.93MM |
| R&D Expense | $346.83MM | $364.20MM | $369.91MM |
| Income(Loss) | $641.20MM | $608.96MM | $585.29MM |
| Taxes | $196.15MM | $187.60MM | $174.94MM |
| Profit(Loss)* | $445.05MM | $421.36MM | $410.35MM |
| Stockholders Equity | $3,630.49MM | $3,851.99MM | $4,049.15MM |
| Inventory | $296.90MM | $254.29MM | $226.34MM |
| Assets | $6,083.88MM | $6,214.60MM | $6,233.69MM |
| Operating Cash Flow | $785.78MM | $738.23MM | $593.22MM |
| Capital expenditure | $177.72MM | $115.58MM | $102.44MM |
| Investing Cash Flow | $-195.94MM | $-254.91MM | $-112.44MM |
| Financing Cash Flow | $-598.34MM | $-355.72MM | $-464.58MM |
| Earnings Per Share** | $5.82 | $5.63 | $5.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.